NO.01↓ 21%
Participants counted30
Heat, past 24hPeak 12 · 14h ago
24h agonow
and 30 other sources reporting·30 participants
63
Heat index
AACR Annual Meeting 2026
April 17–22, 2026 · San Diego · 2418 items
Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.
NO.02↓ 29%
zoldonrasib
16 sources · 16 participants
29
NO.03Building↑ 23%
#BREASTCANCER
7 sources · 7 participants
22
Page 1 No.04–20
Participants · trend · heat index- 04
#PANCREATICCANCER
20flat20flat - 05
elisrasibBuilding
19↑ 29%19↑ 29% - 06
nivolumabBuilding
13↑ 169%13↑ 169% - 07
#NSCLC
13↓ 29%13↓ 29% - 08
#OVARIANCANCERBuilding
12↑ 230%12↑ 230% - 09
daraxonrasibBuilding
12↑ 360%12↑ 360% - 10
#ANNUALMEETING
11↓ 29%11↓ 29% - 11
EGFR
10↓ 29%10↓ 29% - 12
#STANDUPTOCANCERBuilding
10↑ 836%10↑ 836% - 13
DLL3Building
10↑ 910%10↑ 910% - 14
#LUNGCANCER
10↓ 29%10↓ 29% - 15
MEK
10↓ 29%10↓ 29% - 16
#CART
9↓ 29%9↓ 29% - 17
AMX-883
9↓ 29%9↓ 29% - 18
zedoresertib
7↓ 29%7↓ 29% - 19
olaparib
7↓ 29%7↓ 29% - 20
#MMSM
7↓ 29%7↓ 29%